Literature DB >> 25750485

Central Neuropathic Pain in Spinal Cord Injury.

Sujin Lee1, Xing Zhao1, Maya Hatch2, Sophia Chun3, Eric Chang1.   

Abstract

Spinal cord injury (SCI) is a devastating medical condition affecting 1.2 million people in the United States. Central neuropathic pain is one of the most common medical complications of SCI. Current treatment options include opioids, antiepileptic agents such as gabapentin, antispastic agents such as baclofen or tizanidine, and tricyclic acid. Other options include complementary, nonpharmacological treatment such as exercise or acupuncture, interventional treatments, and psychological approaches. Although these treatment options exist, central neuropathic pain in patients with SCI is still extremely difficult to treat because of its complexity. To develop and provide more effective treatment options to these patients, proper assessment of and classification tools for central neuropathic pain, as well as a better understanding of the pathophysiology, are needed. A combination of approaches, from standard general pain assessments to medically specific questions unique to SCI pathophysiology, is essential for this population. A multidisciplinary approach to patient care, in addition with a better understanding of pathophysiology and diagnosis, will lead to improved management and treatment of patients with SCI displaying central neuropathic pain. Here we summarize the most recent classification tools, pathophysiology, and current treatment options for patients with SCI with central neuropathic pain.

Entities:  

Keywords:  central pain; neuropathic pain; pathophysiology; spinal cord injury; treatment

Year:  2013        PMID: 25750485      PMCID: PMC4350234          DOI: 10.1615/CritRevPhysRehabilMed.2013007944

Source DB:  PubMed          Journal:  Crit Rev Phys Rehabil Med        ISSN: 0896-2960


  50 in total

1.  Recommendations for using opioids in chronic non-cancer pain.

Authors:  Eija Kalso; Laurie Allan; Paul L I Dellemijn; Clara C Faura; Wilfried K Ilias; Troels S Jensen; Serge Perrot; Leon H Plaghki; Michael Zenz
Journal:  Eur J Pain       Date:  2003       Impact factor: 3.931

2.  Impact of spinal cord injury on self-perceived pre- and postmorbid cognitive, emotional and physical functioning.

Authors:  R F Murray; A Asghari; D D Egorov; S B Rutkowski; P J Siddall; R J Soden; R Ruff
Journal:  Spinal Cord       Date:  2007-01-16       Impact factor: 2.772

3.  Characterization of chronic pain and somatosensory function in spinal cord injury subjects.

Authors:  R Defrin; A Ohry; N Blumen; G Urca
Journal:  Pain       Date:  2001-01       Impact factor: 6.961

4.  Effect of intrathecal baclofen on evoked pain perception: an evoked potentials and quantitative thermal testing study.

Authors:  H Kumru; M Kofler; M C Flores; E Portell; V Robles; N Leon; J Vidal
Journal:  Eur J Pain       Date:  2012-12-14       Impact factor: 3.931

5.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy.

Authors:  M B Max; S A Lynch; J Muir; S E Shoaf; B Smoller; R Dubner
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

6.  Pain classification following spinal cord injury: the utility of verbal descriptors.

Authors:  J D Putzke; J S Richards; B L Hicken; T J Ness; L Kezar; M DeVivo
Journal:  Spinal Cord       Date:  2002-03       Impact factor: 2.772

7.  The interaction between antidepressant drugs and the pain-relieving effect of spinal cord stimulation in a rat model of neuropathy.

Authors:  Zhiyang Song; Björn A Meyerson; Bengt Linderoth
Journal:  Anesth Analg       Date:  2011-07-25       Impact factor: 5.108

Review 8.  Pain following spinal cord injury: the clinical problem and experimental studies.

Authors:  R P Yezierski
Journal:  Pain       Date:  1996-12       Impact factor: 6.961

9.  The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury.

Authors:  A Kvarnström; R Karlsten; H Quiding; T Gordh
Journal:  Acta Anaesthesiol Scand       Date:  2004-04       Impact factor: 2.105

10.  Development and validation of the Neuropathic Pain Symptom Inventory.

Authors:  Didier Bouhassira; Nadine Attal; Jacques Fermanian; Haiel Alchaar; Michèle Gautron; Etienne Masquelier; Sylvie Rostaing; Michel Lanteri-Minet; Elisabeth Collin; Jacques Grisart; François Boureau
Journal:  Pain       Date:  2004-04       Impact factor: 6.961

View more
  8 in total

1.  Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?

Authors:  Giuseppe Forte; Valentina Giuffrida; Angelica Scuderi; Mariella Pazzaglia
Journal:  Biomedicines       Date:  2022-06-10

2.  Frequency of neuropathic pain and its effects on rehabilitation outcomes, balance function and quality of life among people with traumatic spinal cord injury.

Authors:  Muhammad Idrees Khan; Aatik Arsh; Ikram Ali; Aman Khan Afridi
Journal:  Pak J Med Sci       Date:  2022 Mar-Apr       Impact factor: 2.340

3.  The analgesic effect of intravenous methylprednisolone on acute neuropathic pain with allodynia due to central cord syndrome: a retrospective study.

Authors:  Liandong Li; Yawei Han; Tengshuai Li; Jiaming Zhou; Chao Sun; Yuan Xue
Journal:  J Pain Res       Date:  2018-06-25       Impact factor: 3.133

4.  GABA promotes survival and axonal regeneration in identifiable descending neurons after spinal cord injury in larval lampreys.

Authors:  Daniel Romaus-Sanjurjo; Rocío Ledo-García; Blanca Fernández-López; Kendra Hanslik; Jennifer R Morgan; Antón Barreiro-Iglesias; María Celina Rodicio
Journal:  Cell Death Dis       Date:  2018-06-28       Impact factor: 8.469

Review 5.  Neuropathic pain and Kv7 voltage-gated potassium channels: The potential role of Kv7 activators in the treatment of neuropathic pain.

Authors:  Alaa Abd-Elsayed; Markus Jackson; Steven L Gu; Kenneth Fiala; Jianguo Gu
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  A one-year prospective study on the occurrence of traumatic spinal cord injury and clinical complications during hospitalisation in North-East Tanzania.

Authors:  Haleluya I Moshi; Gunnevi G Sundelin; Klas G Sahlen; Ann Vm Sörlin
Journal:  Afr Health Sci       Date:  2021-06       Impact factor: 0.927

Review 7.  Microglial voltage-gated proton channel Hv1 in spinal cord injury.

Authors:  Jiaying Zheng; Madhuvika Murugan; Lingxiao Wang; Long-Jun Wu
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

Review 8.  Peripheral Immune Dysfunction: A Problem of Central Importance after Spinal Cord Injury.

Authors:  Marisa A Jeffries; Veronica J Tom
Journal:  Biology (Basel)       Date:  2021-09-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.